Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Allergan Ltd, Marlow International, The Parkway, Marlow, Bucks SL7 1YL, United Kingdom
EXOCIN 3 mg/ml Eye Drops, Solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. Clear, pale to light yellow-green solution, practically free from visible particles. |
One millilitre contains 3 mg ofloxacin.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ofloxacin |
Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Benzalkonium chloride (EP) 0.005% w/v |
A bottle and an applicator tip of low density polyethylene (LDPE) and medium or high impact polystyrene cap.
The bottle contains 5 ml or 10 ml of suspension.
Not all pack sizes may be marketed.
Allergan Ltd, Marlow International, The Parkway, Marlow, Bucks SL7 1YL, United Kingdom
PL 00426/0070
Date of first authorisation: 26th October 1992
Date of last renewal: 8th November 2004
| Drug | Countries | |
|---|---|---|
| EXOCIN | Spain, Finland, Ireland, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
